Commercial real-time reverse transcriptase PCR assays can underestimate or fail to quantify hepatitis delta virus viremia

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 6, 2013, Pages 734-740

  Brichler, Ségolène ^a,b   Le Gal, Frédéric ^a,b   Butt, Afifaa ^a,b   Chevret, Sylvie ^c,d,e   Gordien, Emmanuel ^a,b  

^a EA3406   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c HÔpital Saint Louis   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e INSERM   (France)

Author keywords

Diagnosis; Screen; Test; Virology

Indexed keywords

RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; DELTA AGENT HEPATITIS; GENOTYPE; GEOGRAPHIC ORIGIN; HEPATITIS DELTA VIRUS; HUMAN; LIMIT OF QUANTITATION; LONGITUDINAL STUDY; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; VIREMIA; VIRUS LOAD; VIRUS STRAIN;

AFRICA; ASIA; DIAGNOSTIC ERRORS; EUROPE; FEMALE; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; LONGITUDINAL STUDIES; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL LOAD; VIREMIA;

EID: 84878161230     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.01.025     Document Type: Article

References (27)

1. Taylor J.M. Hepatitis delta virus. Virology 2006, 344:71-76.
2. Radjef N., Gordien E., Ivaniushina V., et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol 2004, 78:2537-2544.
3. Le Gal F., Gault E., Ripault M.P., et al. Eighth major clade for hepatitis delta virus. Emerg Infect Dis 2006, 12:1447-1450.
4. Pascarella S., Negro F. Hepatitis D virus: an update. Liver Int 2011, 31:7-21.
5. Cross T.J., Rizzi P., Horner M., et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 2008, 80:277-282.
6. De Paschale M., Manco M.T., Belvisi L., et al. Epidemiology of hepatitis D virus (HDV) infection in an urban area of Northern Italy. Infection 2012, 40:485-491.
7. Genné D., Rossi I. Hepatitis delta in Switzerland: a silent epidemic. Swiss Med Wkly 2011, 141:w13176.
8. Heidrich B., Deterding K., Tillmann H.L., et al. Virological and clinical characteristics of delta hepatitis in central Europe. J Viral Hepat 2009, 16:883-894.
9. Reinheimer C., Doerr H.W., Berger A. Hepatitis delta: on soft paws across Germany. Infection 2012, 40:621-625.
10. Bahcecioglu I.H., Aygun C., Gozel N., et al. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider. J Viral Hepat 2011, 18:518-524.
11. Wedemeyer H., Manns M.P. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 2010, 7:31-40.
12. Castelnau C., Le Gal F., Ripault M.P., et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 2006, 44:728-735.
13. Abbas Z., Khan M.A., Salih M., et al. Interferon alpha for chronic hepatitis D. Cochrane Database Syst Rev 2011, 12. 006002.
14. Wedemeyer H., Yurdaydìn C., Dalekos G.N., et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 2011, 364:322-331.
15. Mederacke I., Yurdaydin C., Dalekos G.N., et al. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment. Antivir Ther 2012, 17:305-312.
16. Hughes S.A., Wedemeyer H., Harrison P.M. Hepatitis delta virus. Lancet 2011, 378:73-85.
17. Le Gal F., Gordien E., Affolabi D., et al. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J Clin Microbiol 2005, 43:2363-2369.
18. Turnbull B. Nonparametric estimation of a survivorship function with doubly censored data. J Am Stat Assoc 1974, 69:169-174.
19. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
20. Helsel D. Non detect and data analysis statistics for censored environmental data 2005, John Wiley and Sons, New York, NY.
21. Hewett P., Ganser G.H. A comparison of several methods for analyzing censored data. Ann Occup Hyg 2007, 51:611-632.
22. Lubin J.H., Colt J.S., Camann D., et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect 2004, 112:1691-1696.
23. Mederacke I., Bremer B., Heidrich B., et al. Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics. J Clin Microbiol 2010, 48:2022-2029.
24. Ferns R.B., Nastouli E., Garson J.A. Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard. J Virol Methods 2012, 179:189-194.
25. Hofmann J., Frenzel K., Minh B.Q., et al. Quantitative detection and typing of hepatitis D virus in human serum by real-time polymerase chain reaction and melting curve analysis. Diagn Microbiol Infect Dis 2010, 67:172-179.
26. Scholtes C., Icard V., Amiri M., et al. Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a heterologous internal-control RNA. J Clin Microbiol 2012, 50:2126-2128.
27. Shang D., Hughes S.A., Horner M., et al. Development and validation of an efficient in-house real-time reverse transcription polymerase chain reaction assay for the quantitative detection of serum hepatitis delta virus RNA in a diverse South London population. J Virol Methods 2012, 184:55-62.